BioNote, Inc. (KRX:377740)
5,840.00
+280.00 (5.04%)
At close: Jan 30, 2026
21.92% (1Y)
| Market Cap | 591.95B |
| Revenue (ttm) | 115.09B +15.3% |
| Net Income | 117.65B +191.5% |
| EPS | 1,160.97 +193.9% |
| Shares Out | 101.36M |
| PE Ratio | 5.03 |
| Forward PE | n/a |
| Dividend | 200.00 (3.60%) |
| Ex-Dividend Date | n/a |
| Volume | 634,668 |
| Average Volume | 111,741 |
| Open | 5,660.00 |
| Previous Close | 5,560.00 |
| Day's Range | 5,660.00 - 5,960.00 |
| 52-Week Range | 4,150.00 - 6,320.00 |
| Beta | 0.92 |
| RSI | 69.20 |
| Earnings Date | Feb 24, 2026 |